Stealthy biotech buys up patent portfolios in string of recent deals
Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months
Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months
NortonLifeLock has pledged to appeal the jury verdict, which could balloon to $550 million with enhanced damages for wilful infringement
Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech
25 March 2021
25 March 2021
25 March 2021
Xavier Becerra may push for anti-patentee policies at HHS, but much remains unknown about the Biden administration’s approach
23 March 2021
Get unlimited access to all IAM content